Design and methods of the Care Management for the Effective Use of Opioids (CAMEO) trial.

Care management Chronic low back pain Cognitive behavioral therapy Collaborative care Long-term opioid therapy Randomized clinical trial

Journal

Contemporary clinical trials
ISSN: 1559-2030
Titre abrégé: Contemp Clin Trials
Pays: United States
ID NLM: 101242342

Informations de publication

Date de publication:
07 2021
Historique:
received: 08 02 2021
revised: 01 04 2021
accepted: 10 04 2021
pubmed: 29 5 2021
medline: 25 9 2021
entrez: 28 5 2021
Statut: ppublish

Résumé

Low back pain is the most common pain condition seen in primary care, with the most common treatment being analgesic medications, including opioids. A dramatic increase in opioid prescriptions for low back pain over the past few decades has led to increased non-medical use and opioid overdose deaths. Cognitive behavioral therapy (CBT) for chronic pain is an evidence-based non-pharmacological treatment for pain with demonstrated efficacy when delivered using collaborative care models. No previous studies have tested CBT compared to analgesic optimization that includes opioid management in primary care. This paper describes the study design and methods of the CAre Management for the Effective use of Opioids (CAMEO) trial, a 2-arm, randomized comparative effectiveness trial in seven primary care clinics. CAMEO enrolled 261 primary care veterans with chronic (6 months or longer) low back pain of at least moderate severity who were receiving long-term opioid therapy and randomized them to either nurse care management focused on analgesic treatment and optimization (MED) or cognitive behavioral therapy (CBT). All subjects undergo comprehensive outcome assessments at baseline, 3, 6, 9, and 12 months by interviewers blinded to treatment assignment. The primary outcome is pain severity and interference, measured by the Brief Pain Inventory (BPI) total score. Secondary outcomes include health-related quality of life, fatigue, sleep, functional improvement, pain disability, pain beliefs, alcohol and opioid problems, depression, anxiety, and stress.

Identifiants

pubmed: 34048943
pii: S1551-7144(21)00192-0
doi: 10.1016/j.cct.2021.106456
pii:
doi:

Substances chimiques

Analgesics 0
Analgesics, Opioid 0

Types de publication

Journal Article Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

106456

Subventions

Organisme : HSRD VA
ID : IK6 HX002715
Pays : United States

Informations de copyright

Published by Elsevier Inc.

Auteurs

Michael A Bushey (MA)

Indiana University School of Medicine, Department of Psychiatry, 355 W 16(th) Street, Suite 4800, Indianapolis, IN 46033, USA.

James Slaven (J)

Indiana University School of Medicine, Department of Biostatistics & Heath Data Science, 410 W 10(th) St, Suite 3000, Indianapolis, IN 46202, USA.

Samantha D Outcalt (SD)

Indiana University School of Medicine, Department of Psychiatry, 355 W 16(th) Street, Suite 4800, Indianapolis, IN 46033, USA; VA HSR&D Center for Health Information and Communication, Roudebush VA Medical Center, 1481 W 10(th) Street, Indianapolis, IN 46202, USA.

Kurt Kroenke (K)

Indiana University School of Medicine, Department of Medicine, 535 Barnhill Drive, Indianapolis, IN 46202, USA; Regenstrief Institute, Inc., 1101 West 10(th) Street, Indianapolis, IN 46202, USA.

Carol Kempf (C)

VA HSR&D Center for Health Information and Communication, Roudebush VA Medical Center, 1481 W 10(th) Street, Indianapolis, IN 46202, USA.

Amanda Froman (A)

VA HSR&D Center for Health Information and Communication, Roudebush VA Medical Center, 1481 W 10(th) Street, Indianapolis, IN 46202, USA.

Christy Sargent (C)

VA HSR&D Center for Health Information and Communication, Roudebush VA Medical Center, 1481 W 10(th) Street, Indianapolis, IN 46202, USA.

Brad Baecher (B)

VA HSR&D Center for Health Information and Communication, Roudebush VA Medical Center, 1481 W 10(th) Street, Indianapolis, IN 46202, USA.

Alan Zillich (A)

Purdue University College of Pharmacy, Department of Pharmacy Practice, 575 Stadium Mall Drive, West Lafayette, IN 47906, USA.

Teresa M Damush (TM)

VA HSR&D Center for Health Information and Communication, Roudebush VA Medical Center, 1481 W 10(th) Street, Indianapolis, IN 46202, USA; Indiana University School of Medicine, Department of Medicine, 535 Barnhill Drive, Indianapolis, IN 46202, USA; Regenstrief Institute, Inc., 1101 West 10(th) Street, Indianapolis, IN 46202, USA.

Chandan Saha (C)

Indiana University School of Medicine, Department of Biostatistics & Heath Data Science, 410 W 10(th) St, Suite 3000, Indianapolis, IN 46202, USA.

Dustin D French (DD)

Northwestern University Feinberg School of Medicine, Department of Ophthalmology, 645 N Michigan Ave, Suite 440, Chicago, IL 60611, USA; Center Health Services and Outcomes Research, 633 N St. Clair Street, Suite 2000, Chicago, IL 60611, USA; VA Health Services Research and Development Service, 820 S Damen Ave, Chicago, IL 60612, USA.

Matthew J Bair (MJ)

VA HSR&D Center for Health Information and Communication, Roudebush VA Medical Center, 1481 W 10(th) Street, Indianapolis, IN 46202, USA; Indiana University School of Medicine, Department of Medicine, 535 Barnhill Drive, Indianapolis, IN 46202, USA; Regenstrief Institute, Inc., 1101 West 10(th) Street, Indianapolis, IN 46202, USA. Electronic address: mbair@iu.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH